Search research articles
Contact Us
Filters
Showing results (151-160 of 325) with videos related to
Page
of 33
Sort By:
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial
Kara W Chew, Carlee Moser, Eunice Yeh, et al.
The Journal of International Medical Research
|
June 14, 2017
Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons
Kara W Chew, Chia-Ying Liu, Bharath Ambale-Venkatesh, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
AIDS (London, England)
|
December 1, 2012
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
James H Stein, Todd T Brown, Heather J Ribaudo, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 10, 2018
Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry
Nhi Phung, Karen Kuncze, Hideaki Okochi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2015
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, James H Stein, et al.
Antiviral Therapy
|
February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir
Scott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2003
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
Constance A Benson, Paige L Williams, Judith S Currier, et al.
Journal of Virology
|
January 18, 2008
Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination
Arumugam Balamurugan, Martha J Lewis, Christina M R Kitchen, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 325) with videos related to
Sort By:
Page
of 33
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial
Kara W Chew, Carlee Moser, Eunice Yeh, et al.
The Journal of International Medical Research
|
June 14, 2017
Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons
Kara W Chew, Chia-Ying Liu, Bharath Ambale-Venkatesh, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
AIDS (London, England)
|
December 1, 2012
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
James H Stein, Todd T Brown, Heather J Ribaudo, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 10, 2018
Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry
Nhi Phung, Karen Kuncze, Hideaki Okochi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2015
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, James H Stein, et al.
Antiviral Therapy
|
February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir
Scott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2003
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
Constance A Benson, Paige L Williams, Judith S Currier, et al.
Journal of Virology
|
January 18, 2008
Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination
Arumugam Balamurugan, Martha J Lewis, Christina M R Kitchen, et al.
Page
of 33